{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:48:06Z","timestamp":1740138486400,"version":"3.37.3"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12035-024-03999-8","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T11:01:36Z","timestamp":1709550096000},"page":"7877-7889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive Insight into the Functional Roles of NK and NKT Cells in HTLV-1-Associated Diseases and Asymptomatic Carriers"],"prefix":"10.1007","volume":"61","author":[{"given":"Maryam","family":"Mahdifar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Boostani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham P.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1061-5864","authenticated-orcid":false,"given":"Houshang","family":"Rafatpanah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"3999_CR1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-800147-9.00005-4","volume":"124","author":"C Watzl","year":"2014","unstructured":"Watzl C (2014) How to trigger a killer: modulation of natural killer cell reactivity on many levels. Adv Immunol 124:137\u2013170","journal-title":"Adv Immunol"},{"issue":"7","key":"3999_CR2","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/eji.200939451","volume":"39","author":"CR Bangham","year":"2009","unstructured":"Bangham CR (2009) CTL quality and the control of human retroviral infections. Eur J Immunol 39(7):1700\u20131712","journal-title":"Eur J Immunol"},{"issue":"4","key":"3999_CR3","doi-asserted-by":"crossref","first-page":"e1010416","DOI":"10.1371\/journal.ppat.1010416","volume":"18","author":"R Moles","year":"2022","unstructured":"Moles R et al (2022) NK cells and monocytes modulate primary HTLV-1 infection. PLoS Pathog 18(4):e1010416","journal-title":"PLoS Pathog"},{"issue":"6013","key":"3999_CR4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","volume":"331","author":"E Vivier","year":"2011","unstructured":"Vivier E et al (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331(6013):44\u201349","journal-title":"Science"},{"issue":"6","key":"3999_CR5","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/1529-0131(200006)43:6<1204::AID-ANR3>3.0.CO;2-I","volume":"43","author":"WE Seaman","year":"2000","unstructured":"Seaman WE (2000) Natural killer cells and natural killer T cells. Arthritis Rheum 43(6):1204\u20131217","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3999_CR6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12879-019-4032-1","volume":"19","author":"GAN Queiroz","year":"2019","unstructured":"Queiroz GAN et al (2019) Functional capacity of natural killer cells in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients. BMC Infect Dis 19(1):433","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3999_CR7","doi-asserted-by":"crossref","first-page":"11.9 B. 1","DOI":"10.1002\/0471142735.im1109bs90","volume":"90","author":"C Watzl","year":"2010","unstructured":"Watzl C, Long EO (2010) Signal transduction during activation and inhibition of natural killer cells. Curr Protoc Immunol 90(1):11.9 B. 1-11.9 B. 17","journal-title":"Curr Protoc Immunol"},{"key":"3999_CR8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.14.1.619","volume":"14","author":"A Moretta","year":"1996","unstructured":"Moretta A et al (1996) Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 14:619\u2013648","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"3999_CR9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nri2604","volume":"9","author":"DH Raulet","year":"2009","unstructured":"Raulet DH, Guerra N (2009) Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol 9(8):568\u2013580","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"3999_CR10","first-page":"461","volume":"112","author":"MA Caligiuri","year":"2008","unstructured":"Caligiuri MA (2008) Human natural killer cells. Blood J Am Soc Hematol 112(3):461\u2013469","journal-title":"Blood J Am Soc Hematol"},{"issue":"8","key":"3999_CR11","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ni.2050","volume":"12","author":"J Thiery","year":"2011","unstructured":"Thiery J et al (2011) Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells. Nat Immunol 12(8):770","journal-title":"Nat Immunol"},{"issue":"10","key":"3999_CR12","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/eji.200324070","volume":"33","author":"RP Wallin","year":"2003","unstructured":"Wallin RP et al (2003) Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur J Immunol 33(10):2727\u20132735","journal-title":"Eur J Immunol"},{"issue":"4","key":"3999_CR13","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.4049\/jimmunol.163.4.1906","volume":"163","author":"N Kayagaki","year":"1999","unstructured":"Kayagaki N et al (1999) Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J Immunol 163(4):1906\u20131913","journal-title":"J Immunol"},{"key":"3999_CR14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","volume":"25","author":"A Bendelac","year":"2007","unstructured":"Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25:297\u2013336","journal-title":"Annu Rev Immunol"},{"key":"3999_CR15","doi-asserted-by":"crossref","unstructured":"Khalesi Z et al (2023) Association between human herpesviruses and multiple sclerosis: a systematic review and meta-analysis. Microb Pathog 177:106031","DOI":"10.1016\/j.micpath.2023.106031"},{"issue":"5","key":"3999_CR16","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2217\/fvl-2021-0096","volume":"17","author":"S Ghorbani","year":"2022","unstructured":"Ghorbani S et al (2022) Association between human herpesvirus-6 and primary brain tumors: a systematic review and meta-analysis. Futur Virol 17(5):305\u2013314","journal-title":"Futur Virol"},{"key":"3999_CR17","doi-asserted-by":"crossref","unstructured":"Maskouni EJ et al (2023) Association between Epstein-Bar virus and colorectal cancer: A systematic review and meta-analysis. Microb Pathog 179:106087","DOI":"10.1016\/j.micpath.2023.106087"},{"key":"3999_CR18","doi-asserted-by":"crossref","unstructured":"Uchiyama T et al (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases","DOI":"10.1182\/blood.V50.3.481.481"},{"key":"3999_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","volume":"ii","author":"A Gessain","year":"1985","unstructured":"Gessain A, de The G et al (1985) Antibodies to human T-lymphotropic virus I in patients with tropical spastic paraparesis. Lancet ii:407\u2013410","journal-title":"Lancet"},{"key":"3999_CR20","doi-asserted-by":"crossref","unstructured":"Osame M et al (1986) HTLV-1 associated myelopathy. A new clinical entity. Lancet 1(8488):1031\u20131032","DOI":"10.1016\/S0140-6736(86)91298-5"},{"key":"3999_CR21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3389\/fmicb.2012.00270","volume":"3","author":"K Kamoi","year":"2012","unstructured":"Kamoi K, Mochizuki M (2012) HTLV-1 uveitis. Front Microbiol 3:270","journal-title":"Front Microbiol"},{"issue":"1","key":"3999_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/cid\/cir766","volume":"54","author":"L Einsiedel","year":"2012","unstructured":"Einsiedel L et al (2012) Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population. Clin Infect Dis 54(1):43\u201350","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3999_CR23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12032-023-02166-8","volume":"40","author":"A Letafati","year":"2023","unstructured":"Letafati A et al (2023) Therapeutic approaches for HTLV-1-associated adult T-cell leukemia\/lymphoma: a comprehensive review. Med Oncol 40(10):295","journal-title":"Med Oncol"},{"key":"3999_CR24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2016.10.015","volume":"137","author":"L Willems","year":"2017","unstructured":"Willems L et al (2017) Reducing the global burden of HTLV-1 infection: an agenda for research and action. Antiviral Res 137:41\u201348","journal-title":"Antiviral Res"},{"issue":"6","key":"3999_CR25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1704827","volume":"378","author":"T Sato","year":"2018","unstructured":"Sato T et al (2018) Mogamulizumab (Anti-CCR4) in HTLV-1\u2013associated myelopathy. N Engl J Med 378(6):529\u2013538","journal-title":"N Engl J Med"},{"issue":"11","key":"3999_CR26","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/jvi.64.11.5682-5687.1990","volume":"64","author":"JH Richardson","year":"1990","unstructured":"Richardson JH et al (1990) In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol 64(11):5682\u20135687","journal-title":"J Virol"},{"issue":"5","key":"3999_CR27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1074-7613(00)00065-0","volume":"13","author":"E Hanon","year":"2000","unstructured":"Hanon E et al (2000) Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 13(5):657\u2013664","journal-title":"Immunity"},{"issue":"6","key":"3999_CR28","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/blood.V98.6.1858","volume":"98","author":"M Nagai","year":"2001","unstructured":"Nagai M et al (2001) CD8(+) T cells are an in vivo reservoir for human T-cell lymphotropic virus type I. Blood 98(6):1858\u20131861","journal-title":"Blood"},{"issue":"9","key":"3999_CR29","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1089\/aid.1992.8.1699","volume":"8","author":"SE Macatonia","year":"1992","unstructured":"Macatonia SE et al (1992) Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retrovir 8(9):1699\u20131706","journal-title":"AIDS Res Hum Retrovir"},{"issue":"6","key":"3999_CR30","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1128\/JVI.73.6.4575-4581.1999","volume":"73","author":"M Makino","year":"1999","unstructured":"Makino M et al (1999) The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy\/tropical spastic paraparesis. J Virol 73(6):4575\u20134581","journal-title":"J Virol"},{"issue":"8","key":"3999_CR31","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3390\/v3081374","volume":"3","author":"C Journo","year":"2011","unstructured":"Journo C, Mahieux R (2011) HTLV-1 and innate immunity. Viruses 3(8):1374\u20131394","journal-title":"Viruses"},{"issue":"1\u20132","key":"3999_CR32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-510X(02)00413-6","volume":"207","author":"M Puccioni-Sohler","year":"2003","unstructured":"Puccioni-Sohler M et al (2003) Pathological and virological assessment of acute HTLV-I-associated myelopathy complicated with encephalopathy and systemic inflammation. J Neurol Sci 207(1\u20132):87\u201393","journal-title":"J Neurol Sci"},{"issue":"5","key":"3999_CR33","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood.V98.5.1506","volume":"98","author":"JA Sakai","year":"2001","unstructured":"Sakai JA et al (2001) In vitro spontaneous lymphoproliferation in patients with human T-cell lymphotropic virus type I-associated neurologic disease: predominant expansion of CD8+ T cells. Blood 98(5):1506\u20131511","journal-title":"Blood"},{"key":"3999_CR34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/1-59259-110-8:159","volume-title":"Retroviral Immunology","author":"SS Soldan","year":"2001","unstructured":"Soldan SS, Jacobson S (2001) Immune response to HTLV-I and HTLV-II. Retroviral Immunology. Springer, pp 159\u2013190"},{"key":"3999_CR35","doi-asserted-by":"crossref","first-page":"D138","DOI":"10.2741\/Yao","volume":"5","author":"J Yao","year":"2000","unstructured":"Yao J, Wigdahl B (2000) Human T cell lymphotropic virus type I genomic expression and impact on intracellular signaling pathways during neurodegenerative disease and leukemia. Front Biosci 5:D138\u2013D168","journal-title":"Front Biosci"},{"issue":"9","key":"3999_CR36","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.2169\/internalmedicine.31.1132","volume":"31","author":"T Tashiro","year":"1992","unstructured":"Tashiro T et al (1992) Immunological studies on opportunistic infection and the development of adult T-cell leukemia. Intern Med 31(9):1132\u20131136","journal-title":"Intern Med"},{"issue":"12","key":"3999_CR37","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1002\/ijc.21688","volume":"118","author":"A Inagaki","year":"2006","unstructured":"Inagaki A et al (2006) Clinical significance of serum Th1-, Th2-and regulatory T cells-associated cytokines in adult T-cell leukemia\/lymphoma: high interleukin-5 and-10 levels are significant unfavorable prognostic factors. Int J Cancer 118(12):3054\u20133061","journal-title":"Int J Cancer"},{"issue":"2","key":"3999_CR38","doi-asserted-by":"crossref","first-page":"e1006861","DOI":"10.1371\/journal.ppat.1006861","volume":"14","author":"H Kagdi","year":"2018","unstructured":"Kagdi H et al (2018) Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T-lymphotropic virus type 1 infection. PLoS Pathog 14(2):e1006861","journal-title":"PLoS Pathog"},{"issue":"1","key":"3999_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4690-8-100","volume":"8","author":"A Takamori","year":"2011","unstructured":"Takamori A et al (2011) Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers. Retrovirology 8(1):1\u201315","journal-title":"Retrovirology"},{"issue":"1","key":"3999_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-019-0484-z","volume":"16","author":"M Kannagi","year":"2019","unstructured":"Kannagi M et al (2019) Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL. Retrovirology 16(1):1\u201314","journal-title":"Retrovirology"},{"issue":"3","key":"3999_CR41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.410260304","volume":"26","author":"M Yoshida","year":"1989","unstructured":"Yoshida M et al (1989) Increased replication of HTLV-I in HTLV-I\u2013associated myelopathy. Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc 26(3):331\u2013335","journal-title":"Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc"},{"issue":"2","key":"3999_CR42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410290214","volume":"29","author":"Ji Kira","year":"1991","unstructured":"Kira Ji et al (1991) Increased HTLV-I proviral DNA in HTLV-I\u2013associated myelopathy: A quantitative polymerase chain reaction study. Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc 29(2):194\u2013201","journal-title":"Ann Neurol: Off J Am Neurol Assoc Child Neurol Soc"},{"issue":"8","key":"3999_CR43","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","volume":"116","author":"M Iwanaga","year":"2010","unstructured":"Iwanaga M et al (2010) Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 116(8):1211\u20131219","journal-title":"Blood"},{"issue":"2","key":"3999_CR44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-5728(91)90056-D","volume":"33","author":"F Yu","year":"1991","unstructured":"Yu F et al (1991) Natural killer (NK) cells in HTLV-I-associated myelopathy\/tropical spastic paraparesis\u2014decrease in NK cell subset populations and activity in HTLV-I seropositive individuals. J Neuroimmunol 33(2):121\u2013128","journal-title":"J Neuroimmunol"},{"issue":"39","key":"3999_CR45","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1038\/sj.onc.1208970","volume":"24","author":"CR Bangham","year":"2005","unstructured":"Bangham CR, Osame M (2005) Cellular immune response to HTLV-1. Oncogene 24(39):6035\u20136046","journal-title":"Oncogene"},{"issue":"2","key":"3999_CR46","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0042-6822(92)90517-S","volume":"188","author":"CE Parker","year":"1992","unstructured":"Parker CE et al (1992) Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 188(2):628\u2013636","journal-title":"Virology"},{"key":"3999_CR47","doi-asserted-by":"crossref","unstructured":"Amorim CF et al (2019) The role of NK cells in the control of viral infection in HTLV-1 carriers. J Immunol Res 6574828","DOI":"10.1155\/2019\/6574828"},{"issue":"2","key":"3999_CR48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/viro.1996.0643","volume":"226","author":"SA Stewart","year":"1996","unstructured":"Stewart SA et al (1996) HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice. Virology 226(2):167\u2013175","journal-title":"Virology"},{"issue":"18","key":"3999_CR49","doi-asserted-by":"crossref","first-page":"9707","DOI":"10.1128\/JVI.00887-07","volume":"81","author":"P Banerjee","year":"2007","unstructured":"Banerjee P, Feuer G, Barker E (2007) Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and-2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. J Virol 81(18):9707\u20139717","journal-title":"J Virol"},{"issue":"5","key":"3999_CR50","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ijc.2910400510","volume":"40","author":"S Sonoda","year":"1987","unstructured":"Sonoda S et al (1987) Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia\/lymphoma patients and their relatives. Int J Cancer 40(5):629\u2013634","journal-title":"Int J Cancer"},{"issue":"14","key":"3999_CR51","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1128\/JVI.76.14.7010-7019.2002","volume":"76","author":"T Ohashi","year":"2002","unstructured":"Ohashi T et al (2002) Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model. J Virol 76(14):7010\u20137019","journal-title":"J Virol"},{"issue":"13","key":"3999_CR52","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1128\/JVI.75.13.6086-6094.2001","volume":"75","author":"JM Johnson","year":"2001","unstructured":"Johnson JM et al (2001) Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia\/lymphotropic virus type 1 p12(I) protein. J Virol 75(13):6086\u20136094","journal-title":"J Virol"},{"issue":"3","key":"3999_CR53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-3083.2002.01053.x","volume":"55","author":"K K\u00e4rre","year":"2002","unstructured":"K\u00e4rre K (2002) NK cells, MHC class I molecules and the missing self. Scand J Immunol 55(3):221\u2013228","journal-title":"Scand J Immunol"},{"key":"3999_CR54","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-642-59421-2_8","volume-title":"Viral Proteins Counteracting Host Defenses","author":"V Braud","year":"2002","unstructured":"Braud V, Tomasec P, Wilkinson GWG (2002) Viral evasion of natural killer cells during human cytomegalovirus infection. Viral Proteins Counteracting Host Defenses. Springer, pp 117\u2013129"},{"issue":"11","key":"3999_CR55","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.micinf.2012.05.001","volume":"14","author":"S Jost","year":"2012","unstructured":"Jost S, Altfeld M (2012) Evasion from NK cell-mediated immune responses by HIV-1. Microbes Infect 14(11):904\u2013915","journal-title":"Microbes Infect"},{"issue":"5","key":"3999_CR56","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.4049\/jimmunol.1601004","volume":"198","author":"D Urlaub","year":"2017","unstructured":"Urlaub D et al (2017) LFA-1 activation in NK cells and their subsets: influence of receptors, maturation, and cytokine stimulation. J Immunol 198(5):1944\u20131951","journal-title":"J Immunol"},{"issue":"1","key":"3999_CR57","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","volume":"19","author":"A Moretta","year":"2001","unstructured":"Moretta A et al (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19(1):197\u2013223","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"3999_CR58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/sj.emboj.7600019","volume":"23","author":"L Moretta","year":"2004","unstructured":"Moretta L, Moretta A (2004) Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 23(2):255\u2013259","journal-title":"EMBO J"},{"issue":"4","key":"3999_CR59","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1084\/jem.20030788","volume":"198","author":"C Bottino","year":"2003","unstructured":"Bottino C et al (2003) Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 198(4):557\u2013567","journal-title":"J Exp Med"},{"issue":"3","key":"3999_CR60","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ijc.2910520316","volume":"52","author":"K Fukudome","year":"1992","unstructured":"Fukudome K et al (1992) Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines. Int J Cancer 52(3):418\u2013427","journal-title":"Int J Cancer"},{"issue":"8","key":"3999_CR61","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1128\/jvi.64.8.4002-4006.1990","volume":"64","author":"M Sawada","year":"1990","unstructured":"Sawada M et al (1990) Human T-cell leukemia virus type I trans activator induces class I major histocompatibility complex antigen expression in glial cells. J Virol 64(8):4002\u20134006","journal-title":"J Virol"},{"issue":"16","key":"3999_CR62","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1089\/aid.1997.13.1429","volume":"13","author":"SM Owen","year":"1997","unstructured":"Owen SM et al (1997) Transcriptional activation of the intercellular adhesion molecule 1 (CD54) gene by human T lymphotropic virus types I and II Tax is mediated through a palindromic response element. AIDS Res Hum Retrovir 13(16):1429\u20131437","journal-title":"AIDS Res Hum Retrovir"},{"issue":"6","key":"3999_CR63","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.4049\/jimmunol.141.6.1970","volume":"141","author":"N Yoshimura","year":"1988","unstructured":"Yoshimura N et al (1988) Killer cell systems of cynomolgus monkeys experimentally infected with HTLV-1. J Immunol 141(6):1970\u20131974","journal-title":"J Immunol"},{"issue":"4","key":"3999_CR64","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/088922204323048195","volume":"20","author":"TM McGinn","year":"2004","unstructured":"McGinn TM et al (2004) Immune responses to HTLV-I (ACH) during acute infection of pig-tailed macaques. AIDS Res Hum Retrovir 20(4):443\u2013456","journal-title":"AIDS Res Hum Retrovir"},{"issue":"1","key":"3999_CR65","first-page":"21","volume":"39","author":"K Fujihara","year":"1999","unstructured":"Fujihara K (1999) Pathogenetic significance of HTLV-I infection and immune surveillance in HAM. Rinsho Shinkeigaku 39(1):21\u201323","journal-title":"Rinsho Shinkeigaku"},{"issue":"3","key":"3999_CR66","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0145-2126(85)90056-6","volume":"9","author":"L De Vecchis","year":"1985","unstructured":"De Vecchis L et al (1985) Decline of natural cytotoxicity of human lymphocytes following infection with human T-cell leukemia\/lymphoma virus (HTLV). Leuk Res 9(3):349\u2013355","journal-title":"Leuk Res"},{"issue":"12","key":"3999_CR67","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.4049\/jimmunol.149.12.4101","volume":"149","author":"KM Lo","year":"1992","unstructured":"Lo KM et al (1992) Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells. J Immunol 149(12):4101\u20138","journal-title":"J Immunol"},{"issue":"6","key":"3999_CR68","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-3083.2002.01087.x","volume":"55","author":"GE Brito-Melo","year":"2002","unstructured":"Brito-Melo GE et al (2002) Phenotypic study of peripheral blood leucocytes in HTLV-I-infected individuals from Minas Gerais. Brazil Scand J Immunol 55(6):621\u2013628","journal-title":"Brazil Scand J Immunol"},{"issue":"1","key":"3999_CR69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-510X(91)90125-Q","volume":"105","author":"K Fujihara","year":"1991","unstructured":"Fujihara K et al (1991) Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). J Neurol Sci 105(1):99\u2013107","journal-title":"J Neurol Sci"},{"issue":"1","key":"3999_CR70","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0022-510X(00)00322-1","volume":"177","author":"X-M Wu","year":"2000","unstructured":"Wu X-M et al (2000) Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets. J Neurol Sci 177(1):24\u201331","journal-title":"J Neurol Sci"},{"issue":"11","key":"3999_CR71","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2169\/internalmedicine.39.885","volume":"39","author":"A Masuda","year":"2000","unstructured":"Masuda A et al (2000) Psychobehavioral and immunological characteristics of HTLV-1 carriers and non-carriers with persistently low natural killer cell activity. Intern Med 39(11):885\u2013890","journal-title":"Intern Med"},{"issue":"15","key":"3999_CR72","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1182\/blood-2009-02-203042","volume":"114","author":"K Azakami","year":"2009","unstructured":"Azakami K et al (2009) Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders. Blood 114(15):3208\u20133215","journal-title":"Blood"},{"issue":"11","key":"3999_CR73","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22(11):633\u2013640","journal-title":"Trends Immunol"},{"issue":"6669","key":"3999_CR74","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","volume":"391","author":"VM Braud","year":"1998","unstructured":"Braud VM et al (1998) HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C. Nature 391(6669):795\u2013799","journal-title":"Nature"},{"issue":"2","key":"3999_CR75","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood-2002-09-2855","volume":"102","author":"M Saito","year":"2003","unstructured":"Saito M et al (2003) Low frequency of CD94\/NKG2A+ T lymphocytes in patients with HTLV-1\u2013associated myelopathy\/tropical spastic paraparesis, but not in asymptomatic carriers. Blood 102(2):577\u2013584","journal-title":"Blood"},{"issue":"1\u20132","key":"3999_CR76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jns.2005.05.011","volume":"237","author":"T Matsuzaki","year":"2005","unstructured":"Matsuzaki T et al (2005) A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy\/tropical spastic paraparesis. J Neurol Sci 237(1\u20132):75\u201381","journal-title":"J Neurol Sci"},{"issue":"8","key":"3999_CR77","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.4049\/jimmunol.173.8.5121","volume":"173","author":"AM Vine","year":"2004","unstructured":"Vine AM et al (2004) The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1. J Immunol 173(8):5121\u20135129","journal-title":"J Immunol"},{"issue":"3","key":"3999_CR78","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/85321","volume":"2","author":"V Groh","year":"2001","unstructured":"Groh V et al (2001) Costimulation of CD8\u03b1\u03b2 T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2(3):255\u2013260","journal-title":"Nat Immunol"},{"issue":"2","key":"3999_CR79","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4049\/jimmunol.168.2.671","volume":"168","author":"CL Sutherland","year":"2002","unstructured":"Sutherland CL et al (2002) UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells. J Immunol 168(2):671\u2013679","journal-title":"J Immunol"},{"issue":"2","key":"3999_CR80","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1074-7613(01)00095-4","volume":"14","author":"D Cosman","year":"2001","unstructured":"Cosman D et al (2001) ULBPs, novel MHC class I\u2013related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14(2):123\u2013133","journal-title":"Immunity"},{"issue":"6","key":"3999_CR81","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1089\/aid.2013.0214","volume":"30","author":"Y Tanaka","year":"2014","unstructured":"Tanaka Y et al (2014) Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46. AIDS Res Hum Retrovir 30(6):542\u2013552","journal-title":"AIDS Res Hum Retrovir"},{"issue":"1\u20132","key":"3999_CR82","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0022-510X(96)00149-9","volume":"142","author":"K Fujihara","year":"1996","unstructured":"Fujihara K et al (1996) Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). J Neurol Sci 142(1\u20132):65\u201369","journal-title":"J Neurol Sci"},{"issue":"3","key":"3999_CR83","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijc.2910330302","volume":"33","author":"H Miyakoshi","year":"1984","unstructured":"Miyakoshi H, Koide H, Aoki T (1984) In vitro antibody-dependent cellular cytotoxicity against human T-cell leukemia\/lymphoma virus (HTLV)-producing cells. Int J Cancer 33(3):287\u2013291","journal-title":"Int J Cancer"},{"issue":"1","key":"3999_CR84","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1442-200X.1990.tb00778.x","volume":"32","author":"T Kunitomi","year":"1990","unstructured":"Kunitomi T et al (1990) Antibody-dependent cellular cytotoxicity and natural killer activity against HTLV-1 infected cells. Pediatr Int 32(1):16\u201319","journal-title":"Pediatr Int"},{"issue":"39","key":"3999_CR85","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1038\/sj.onc.1208972","volume":"24","author":"N Manel","year":"2005","unstructured":"Manel N et al (2005) HTLV-1 tropism and envelope receptor. Oncogene 24(39):6016\u20136025","journal-title":"Oncogene"},{"issue":"2","key":"3999_CR86","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/08916938809001925","volume":"1","author":"I Kitajima","year":"1988","unstructured":"Kitajima I et al (1988) Immunological studies of HTLV-I associated myelopathy. Autoimmunity 1(2):125\u2013131","journal-title":"Autoimmunity"},{"issue":"1","key":"3999_CR87","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.imlet.2013.03.003","volume":"152","author":"F Bisio","year":"2013","unstructured":"Bisio F et al (2013) Successfully treated HIV-infected patients have differential expression of NK cell receptors (NKp46 and NKp30) according to AIDS status at presentation. Immunol Lett 152(1):16\u201324","journal-title":"Immunol Lett"},{"issue":"1","key":"3999_CR88","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/1471-2334-14-453","volume":"14","author":"R Coutinho","year":"2014","unstructured":"Coutinho R et al (2014) Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers. BMC Infect Dis 14(1):453","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3999_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-4-1","volume":"4","author":"SB Santos","year":"2004","unstructured":"Santos SB et al (2004) Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers. BMC Infect Dis 4(1):1\u20138","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3999_CR90","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/viru.1.1.9868","volume":"1","author":"PJ Norris","year":"2010","unstructured":"Norris PJ et al (2010) Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells. Virulence 1(1):19\u201328","journal-title":"Virulence"},{"issue":"2","key":"3999_CR91","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1365-2567.2007.02573.x","volume":"121","author":"Y Zhang","year":"2007","unstructured":"Zhang Y et al (2007) In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 121(2):258\u2013265","journal-title":"Immunology"},{"issue":"4","key":"3999_CR92","first-page":"1386","volume":"95","author":"E Hanon","year":"2000","unstructured":"Hanon E et al (2000) Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood J Am Soc Hematol 95(4):1386\u20131392","journal-title":"Blood J Am Soc Hematol"},{"issue":"10","key":"3999_CR93","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1084\/jem.186.10.1677","volume":"186","author":"B-N Zhang","year":"1997","unstructured":"Zhang B-N et al (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 186(10):1677\u20131687","journal-title":"J Exp Med"},{"issue":"6855","key":"3999_CR94","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/35097097","volume":"413","author":"K Miyamoto","year":"2001","unstructured":"Miyamoto K, Miyake S, Yamamura T (2001) A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing Th 2 bias of natural killer T cells. Nature 413(6855):531\u2013534","journal-title":"Nature"},{"issue":"4","key":"3999_CR95","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.4049\/jimmunol.160.4.1606","volume":"160","author":"JP Antel","year":"1998","unstructured":"Antel JP et al (1998) Non-MHC-restricted cell-mediated lysis of human oligodendrocytes in vitro: relation with CD56 expression. J Immunol 160(4):1606\u20131611","journal-title":"J Immunol"},{"issue":"1\u20132","key":"3999_CR96","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0165-5728(03)00219-4","volume":"141","author":"J Feng","year":"2003","unstructured":"Feng J et al (2003) Interferon-\u03b1 significantly reduces cerebrospinal fluid CD4 cell subsets in HAM\/TSP. J Neuroimmunol 141(1\u20132):170\u2013173","journal-title":"J Neuroimmunol"},{"issue":"4","key":"3999_CR97","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","volume":"46","author":"S Izumo","year":"1996","unstructured":"Izumo S et al (1996) Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial. Neurology 46(4):1016\u20131021","journal-title":"Neurology"},{"issue":"1","key":"3999_CR98","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00005072-199401000-00009","volume":"53","author":"F Umehara","year":"1994","unstructured":"Umehara F et al (1994) Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 53(1):72\u201377","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"3999_CR99","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00005072-199307000-00010","volume":"52","author":"F Umehara","year":"1993","unstructured":"Umehara F et al (1993) Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 52(4):424\u2013430","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"3999_CR100","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1128\/jvi.69.2.1328-1333.1995","volume":"69","author":"G Feuer","year":"1995","unstructured":"Feuer G et al (1995) Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses. J Virol 69(2):1328\u20131333","journal-title":"J Virol"},{"issue":"6","key":"3999_CR101","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.4049\/jimmunol.134.6.3798","volume":"134","author":"K Dorshkind","year":"1985","unstructured":"Dorshkind K et al (1985) Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol 134(6):3798\u20133801","journal-title":"J Immunol"},{"issue":"4","key":"3999_CR102","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1349-7006.1992.tb00108.x","volume":"83","author":"S Ishihara","year":"1992","unstructured":"Ishihara S et al (1992) Successful graft of HTLV-I-transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-1 antibody. Jpn J Cancer Res 83(4):320\u2013323","journal-title":"Jpn J Cancer Res"},{"key":"3999_CR103","doi-asserted-by":"crossref","unstructured":"Kondo A et al (1993) A model of in vivo cell proliferation of adult T-cell leukemia 82(8):2501\u20132509","DOI":"10.1182\/blood.V82.8.2501.bloodjournal8282501"},{"issue":"6","key":"3999_CR104","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/S0002-9440(10)64694-9","volume":"158","author":"V Richard","year":"2001","unstructured":"Richard V et al (2001) Humoral hypercalcemia of malignancy: severe combined immunodeficient\/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression. Am J Pathol 158(6):2219\u20132228","journal-title":"Am J Pathol"},{"issue":"6","key":"3999_CR105","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0145-2126(01)00169-2","volume":"26","author":"Y Liu","year":"2002","unstructured":"Liu Y et al (2002) Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID\/bg and NOD\/SCID mice. Leuk Res 26(6):561\u2013567","journal-title":"Leuk Res"},{"issue":"4","key":"3999_CR106","first-page":"1083","volume":"62","author":"C Tan","year":"2002","unstructured":"Tan C, Waldmann TA (2002) Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia. Can Res 62(4):1083\u20131086","journal-title":"Can Res"},{"issue":"9","key":"3999_CR107","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1128\/JVI.77.9.5286-5294.2003","volume":"77","author":"MZ Dewan","year":"2003","unstructured":"Dewan MZ et al (2003) Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID\/\u03b3cnull mice: suppression by an inhibitor against NF-\u03baB. J Virol 77(9):5286\u20135294","journal-title":"J Virol"},{"issue":"2","key":"3999_CR108","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/labinvest.3700034","volume":"84","author":"T Ohsugi","year":"2004","unstructured":"Ohsugi T et al (2004) Rapid tumor death model for evaluation of new therapeutic agents for adult T-cell leukemia. Lab Invest 84(2):263\u2013266","journal-title":"Lab Invest"},{"issue":"3","key":"3999_CR109","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1292\/jvms.56.601","volume":"56","author":"T Ohsugi","year":"1994","unstructured":"Ohsugi T et al (1994) Engraftment of HTLV-I-transformed human T-cell line into SCID mice with NK cell function. J Vet Med Sci 56(3):601\u2013603","journal-title":"J Vet Med Sci"},{"issue":"3","key":"3999_CR110","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1182\/blood.V82.3.722.722","volume":"82","author":"G Feuer","year":"1993","unstructured":"Feuer G et al (1993) Establishment of human T-cell leukemia virus type I T-cell lymphomas in severe combined immunodeficient mice. Blood 82(3):722\u2013731","journal-title":"Blood"},{"issue":"9","key":"3999_CR111","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/eji.1830070915","volume":"7","author":"R Kiessling","year":"1977","unstructured":"Kiessling R et al (1977) Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol 7(9):655\u2013663","journal-title":"Eur J Immunol"},{"issue":"12","key":"3999_CR112","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/intimm\/5.12.1509","volume":"5","author":"F Pflumio","year":"1993","unstructured":"Pflumio F et al (1993) Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versus-host disease. Int Immunol 5(12):1509\u20131522","journal-title":"Int Immunol"},{"issue":"19","key":"3999_CR113","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1073\/pnas.81.19.6207","volume":"81","author":"G Franchini","year":"1984","unstructured":"Franchini G, Wong-Staal F, Gallo RC (1984) Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia. Proc Natl Acad Sci 81(19):6207\u20136211","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"3999_CR114","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1073\/pnas.81.8.2534","volume":"81","author":"M Yoshida","year":"1984","unstructured":"Yoshida M et al (1984) Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci 81(8):2534\u20132537","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"3999_CR115","first-page":"367","volume":"4","author":"H Uno","year":"1995","unstructured":"Uno H et al (1995) Altered expression of class I HLA antigen on peripheral mononuclear cells in patients with adult T-cell leukemia: inverse relationship with natural killer susceptibility. Cancer Epidemiol Biomarkers Prev 4(4):367\u2013372","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"3999_CR116","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2169\/internalmedicine.41.34","volume":"41","author":"T Hashiguchi","year":"2002","unstructured":"Hashiguchi T et al (2002) Adult T-cell leukemia (ATL) cells which express neural cell adhesion molecule (NCAM) and infiltrate into the central nervous system. Intern Med 41(1):34\u201338","journal-title":"Intern Med"},{"issue":"11","key":"3999_CR117","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0046-8177(94)90045-0","volume":"25","author":"K Hayashi","year":"1994","unstructured":"Hayashi K et al (1994) A case of neural cell adhesion molecule-positive peripheral T-cell lymphoma associated with human T-cell lymphotrophic virus type 1 showing an unusual involvement of the gastrointestinal tract during the course of the disease. Hum Pathol 25(11):1251\u20131253","journal-title":"Hum Pathol"},{"issue":"1","key":"3999_CR118","first-page":"32","volume":"41","author":"M Koike","year":"2000","unstructured":"Koike M et al (2000) CD56-positive adult T-cell leukemia manifested by abnormal lung shadows. [Rinsho Ketsueki] Jpn J Clin Hematol 41(1):32\u201336","journal-title":"[Rinsho Ketsueki] Jpn J Clin Hematol"},{"issue":"2","key":"3999_CR119","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s004280050405","volume":"435","author":"K Ohshima","year":"1999","unstructured":"Ohshima K et al (1999) Absence of cytotoxic molecules in CD8-and\/or CD56-positive adult T-cell leukaemia\/lymphoma. Virchows Arch 435(2):101\u2013104","journal-title":"Virchows Arch"},{"issue":"1","key":"3999_CR120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00795-014-0072-1","volume":"48","author":"K-J Sugimoto","year":"2015","unstructured":"Sugimoto K-J et al (2015) CD56-positive adult T-cell leukemia\/lymphoma: a case report and a review of the literature. Med Mol Morphol 48(1):54\u201359","journal-title":"Med Mol Morphol"},{"issue":"2","key":"3999_CR121","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1440-1827.2007.02195.x","volume":"58","author":"K Karube","year":"2008","unstructured":"Karube K et al (2008) Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases. Pathol Int 58(2):89\u201397","journal-title":"Pathol Int"},{"issue":"10","key":"3999_CR122","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI0215770","volume":"109","author":"T Decker","year":"2002","unstructured":"Decker T et al (2002) IFNs and STATs in innate immunity to microorganisms. J Clin Investig 109(10):1271\u20131277","journal-title":"J Clin Investig"},{"issue":"1","key":"3999_CR123","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2006.05.025","volume":"10","author":"B Kovacic","year":"2006","unstructured":"Kovacic B et al (2006) STAT1 acts as a tumor promoter for leukemia development. Cancer Cell 10(1):77\u201387","journal-title":"Cancer Cell"},{"issue":"5","key":"3999_CR124","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.neo.2015.04.005","volume":"17","author":"R Moles","year":"2015","unstructured":"Moles R, Bellon M, Nicot C (2015) STAT1: a novel target of miR-150 and miR-223 is involved in the proliferation of HTLV-I\u2013transformed and ATL cells. Neoplasia 17(5):449\u2013462","journal-title":"Neoplasia"},{"issue":"14","key":"3999_CR125","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1128\/JVI.00007-11","volume":"85","author":"S Charoenthongtrakul","year":"2011","unstructured":"Charoenthongtrakul S et al (2011) Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-\u03baB-dependent induction of SOCS1. J Virol 85(14):6955\u20136962","journal-title":"J Virol"},{"issue":"5","key":"3999_CR126","first-page":"791","volume":"121","author":"NL Ko","year":"2013","unstructured":"Ko NL et al (2013) PA28\u03b3 is a novel corepressor of HTLV-1 replication and controls viral latency. Blood J Am Soc Hematol 121(5):791\u2013800","journal-title":"Blood J Am Soc Hematol"},{"issue":"6","key":"3999_CR127","doi-asserted-by":"crossref","first-page":"e66915","DOI":"10.1371\/journal.pone.0066915","volume":"8","author":"Y Fang","year":"2013","unstructured":"Fang Y et al (2013) MEK\/ERK dependent activation of STAT1 mediates dasatinib-induced differentiation of acute myeloid leukemia. PLoS one 8(6):e66915","journal-title":"PLoS one"},{"issue":"8","key":"3999_CR128","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.humimm.2012.05.006","volume":"73","author":"GM O\u2019Connor","year":"2012","unstructured":"O\u2019Connor GM et al (2012) In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection. Hum Immunol 73(8):783\u2013787","journal-title":"Hum Immunol"},{"issue":"4","key":"3999_CR129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng934","volume":"31","author":"MP Martin","year":"2002","unstructured":"Martin MP et al (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31(4):429\u2013434","journal-title":"Nat Genet"},{"issue":"5685","key":"3999_CR130","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","volume":"305","author":"SI Khakoo","year":"2004","unstructured":"Khakoo SI et al (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305(5685):872\u2013874","journal-title":"Science"},{"issue":"10","key":"3999_CR131","doi-asserted-by":"crossref","first-page":"e1002270","DOI":"10.1371\/journal.ppat.1002270","volume":"7","author":"N-KS Al Basatena","year":"2011","unstructured":"Al Basatena N-KS et al (2011) KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog 7(10):e1002270","journal-title":"PLoS Pathog"},{"issue":"10","key":"3999_CR132","doi-asserted-by":"crossref","first-page":"e1002270","DOI":"10.1371\/journal.ppat.1002270","volume":"7","author":"NK Seich Al Basatena","year":"2011","unstructured":"Seich Al Basatena NK et al (2011) KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection. PLoS Pathog 7(10):e1002270","journal-title":"PLoS Pathog"},{"issue":"1","key":"3999_CR133","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virol.2012.09.028","volume":"435","author":"LB Cook","year":"2013","unstructured":"Cook LB et al (2013) HTLV-1: persistence and pathogenesis. Virology 435(1):131\u2013140","journal-title":"Virology"},{"issue":"6","key":"3999_CR134","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.4049\/jimmunol.166.6.3933","volume":"166","author":"NT Young","year":"2001","unstructured":"Young NT et al (2001) Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J Immunol 166(6):3933\u20133941","journal-title":"J Immunol"},{"issue":"2","key":"3999_CR135","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2006-10-052720","volume":"110","author":"C Cerboni","year":"2007","unstructured":"Cerboni C et al (2007) Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM\/ATR-dependent mechanism and become susceptible to autologous NK-cell lysis. Blood 110(2):606\u2013615","journal-title":"Blood"},{"issue":"6","key":"3999_CR136","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.4049\/jimmunol.1004122","volume":"186","author":"K Soderquest","year":"2011","unstructured":"Soderquest K et al (2011) Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses. J Immunol 186(6):3304\u20133308","journal-title":"J Immunol"},{"issue":"7","key":"3999_CR137","first-page":"1493","volume":"113","author":"D Rauch","year":"2009","unstructured":"Rauch D et al (2009) Imaging spontaneous tumorigenesis: inflammation precedes development of peripheral NK tumors. Blood J Am Soc Hematol 113(7):1493\u20131500","journal-title":"Blood J Am Soc Hematol"},{"issue":"6","key":"3999_CR138","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.4049\/jimmunol.153.6.2417","volume":"153","author":"LL Lanier","year":"1994","unstructured":"Lanier LL, Chang C, Phillips JH (1994) Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol 153(6):2417\u201328","journal-title":"J Immunol"},{"issue":"12","key":"3999_CR139","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.4049\/jimmunol.159.12.5862","volume":"159","author":"C Prussin","year":"1997","unstructured":"Prussin C, Foster B (1997) TCR V alpha 24 and V beta 11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J Immunol 159(12):5862\u20135870","journal-title":"J Immunol"},{"issue":"1","key":"3999_CR140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.178.1.1","volume":"178","author":"S Porcelli","year":"1993","unstructured":"Porcelli S et al (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha\/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med 178(1):1\u201316","journal-title":"J Exp Med"},{"issue":"3","key":"3999_CR141","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.180.3.1171","volume":"180","author":"P Dellabona","year":"1994","unstructured":"Dellabona P et al (1994) An invariant V alpha 24-J alpha Q\/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J Exp Med 180(3):1171\u20131176","journal-title":"J Exp Med"},{"issue":"6","key":"3999_CR142","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/eji.200737389","volume":"38","author":"MA Exley","year":"2008","unstructured":"Exley MA et al (2008) Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop. Eur J Immunol 38(6):1756\u20131766","journal-title":"Eur J Immunol"},{"issue":"6","key":"3999_CR143","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.4049\/jimmunol.167.6.3114","volume":"167","author":"LS Metelitsa","year":"2001","unstructured":"Metelitsa LS et al (2001) Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J Immunol 167(6):3114\u20133122","journal-title":"J Immunol"},{"issue":"20","key":"3999_CR144","first-page":"5102","volume":"59","author":"T Kawano","year":"1999","unstructured":"Kawano T et al (1999) Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res 59(20):5102\u20135105","journal-title":"Cancer Res"},{"key":"3999_CR145","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fimmu.2015.00226","volume":"6","author":"L Van Kaer","year":"2015","unstructured":"Van Kaer L, Parekh VV, Wu L (2015) The response of CD1d-restricted invariant NKT cells to microbial pathogens and their products. Front Immunol 6:226","journal-title":"Front Immunol"},{"issue":"1","key":"3999_CR146","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri2451","volume":"9","author":"V Cerundolo","year":"2009","unstructured":"Cerundolo V et al (2009) Harnessing invariant NKT cells in vaccination strategies. Nat Rev Immunol 9(1):28\u201338","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"3999_CR147","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2249.2009.04019.x","volume":"158","author":"L Ndhlovu","year":"2009","unstructured":"Ndhlovu L et al (2009) Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease. Clin Exp Immunol 158(3):294\u2013299","journal-title":"Clin Exp Immunol"},{"issue":"6106","key":"3999_CR148","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/325683a0","volume":"325","author":"J Borst","year":"1987","unstructured":"Borst J et al (1987) A T-cell receptor \u03b3\/CD3 complex found on cloned functional lymphocytes. Nature 325(6106):683\u2013688","journal-title":"Nature"},{"issue":"5","key":"3999_CR149","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.20011786","volume":"195","author":"JE Gumperz","year":"2002","unstructured":"Gumperz JE et al (2002) Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 195(5):625\u2013636","journal-title":"J Exp Med"},{"issue":"5","key":"3999_CR150","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20011908","volume":"195","author":"PT Lee","year":"2002","unstructured":"Lee PT et al (2002) Distinct functional lineages of human V(alpha)24 natural killer T cells. J Exp Med 195(5):637\u2013641","journal-title":"J Exp Med"},{"issue":"7","key":"3999_CR151","doi-asserted-by":"crossref","first-page":"e2328","DOI":"10.1371\/journal.pntd.0002328","volume":"7","author":"JG Coelho-dos-Reis","year":"2013","unstructured":"Coelho-dos-Reis JG et al (2013) Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disorders. PLoS Negl Trop Dis 7(7):e2328","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"3999_CR152","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-4632.2010.04568.x","volume":"49","author":"AL Bittencourt","year":"2010","unstructured":"Bittencourt AL, Oliveira MdFPd (2010) Cutaneous manifestations associated with HTLV-1 infection. Int J Dermatol 49(10):1099\u20131110","journal-title":"Int J Dermatol"},{"issue":"11","key":"3999_CR153","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/exd.12007","volume":"21","author":"NK McGill","year":"2012","unstructured":"McGill NK et al (2012) HTLV-1-associated infective dermatitis: updates on the pathogenesis. Exp Dermatol 21(11):815\u2013821","journal-title":"Exp Dermatol"},{"key":"3999_CR154","doi-asserted-by":"crossref","unstructured":"Imashuku S et al (2014) Expansion of natural killer cells in peripheral blood in a Japanese elderly with human T-cell lymphotropic virus type 1-related skin lesions. Case Rep Dermatol Med 2014:937513","DOI":"10.1155\/2014\/937513"},{"issue":"8","key":"3999_CR155","first-page":"778","volume":"32","author":"Y Inoue","year":"1994","unstructured":"Inoue Y et al (1994) A case of HTLV-1 carrier associated with pulmonary cryptococcosis and thymoma. Nihon Kyobu Shikkan Gakkai Zasshi 32(8):778\u2013784","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-03999-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-03999-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-03999-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T09:25:08Z","timestamp":1726824308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-03999-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":155,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["3999"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-03999-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"assertion":[{"value":"13 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}